Company News

Share this article:

Abbott Animal Health announced a partnership with Velcera, a specialty pharma focused on pet health, to market a canine pain management product delivered in a transmucosal mist form. The Promist technology delivers the active ingredient through a fine mist to the inside cheek or oral cavity of the animal, where it's absorbed through the mucous membranes of the mouth.

Algos Therapeutics changed its name to Algos Preclinical Services, after a shift from developing pain therapy products into pure contract research as a CRO for drug discovery and product development. The company also launched a redesigned website created through a partnership with MVP Marketing + Design.

Concord, MA-based Emerson Hospital tapped Boston-based Partners+Simons to develop a "digital lobby" website for the hospital. The "next-generation" website will be used to emphasize the hospitals dedication to its patients, and to build the brand online, according to a company statement.   


Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.